本页面由Tiger Trade Technology Pte. Ltd.提供服务

Immunovant, Inc.

28.80
-1.6700-5.48%
成交量:81.50万
成交额:2,389.96万
市值:59.44亿
市盈率:-10.22
高:30.60
开:30.17
低:28.61
收:30.47
52周最高:45.42
52周最低:16.60
股本:2.06亿
流通股本:8,956.68万
量比:0.73
换手率:0.91%
股息:- -
股息率:- -
每股收益(TTM):-2.8178
每股收益(LYR):-2.7716
净资产收益率:-80.10%
总资产收益率:-46.73%
市净率:8.08
市盈率(LYR):-10.39

数据加载中...

2026/09/04

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/05/20

重要事件披露

Form 8-K - Current report
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/02/06

重要事件披露

Form 8-K - Current report
2025/12/12

重要事件披露

Form 8-K - Current report
2025/12/11

重要事件披露

Form 8-K - Current report
2025/12/11

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses